DeepMed Research

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

🇵🇰Pakistan

Country: 🇵🇰Pakistan

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Characterization of Phenotypic and Genotypic Regressors for Imaging

Recruiting

Conditions: Healthy Volunteers
Substance Use Disorders

First Posted Date: 2010-06-22

Last Posted Date: 2025-05-20

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 2625

Registration Number: NCT01148381

Locations: 🇺🇸
National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore, Maryland, United States

Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal Spray

Phase 1

Completed

Conditions: Drug Addiction
Nicotine Dependence

First Posted Date: 2010-06-03

Last Posted Date: 2019-12-16

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 43

Registration Number: NCT01136642

Locations: 🇺🇸
National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore, Maryland, United States

Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked Cannabis

Phase 1

Completed

Conditions: Cannabis Use
Drug Abuse

First Posted Date: 2010-02-19

Last Posted Date: 2018-07-05

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 45

Registration Number: NCT01071616

Locations: 🇺🇸
National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore, Maryland, United States

The Neural Basis of Cue-Elicited Cigarette Craving and Its Control

Not Applicable

Completed

Conditions: Nicotine Dependence

First Posted Date: 2010-01-14

Last Posted Date: 2019-12-16

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 79

Registration Number: NCT01048957

Locations: 🇺🇸
National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore, Maryland, United States

fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia

Completed

Conditions: Schizophrenia
Nicotine Dependence
Psychopathology

First Posted Date: 2010-01-12

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 100

Registration Number: NCT01046526

Locations: 🇺🇸
Maryland Psychiatric Research Center (MPRC) 55 Wade Avenue, Catonsville, Maryland, United States

Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults

Phase 1

Completed

Conditions: Substance-Related Disorders

Interventions: Drug: RDC-0313 + Buprenorphine
Drug: Placebo

First Posted Date: 2010-01-12

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 12

Registration Number: NCT01046539

Locations: 🇺🇸
Langley Porter Psychiatric Hospital, San Francisco, California, United States

PET Imaging of Nicotinic Acetylcholine Receptors

Completed

Conditions: Pharmacokinetics
Healthy Volunteers
Nicotine Dependence

First Posted Date: 2010-01-12

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 14

Registration Number: NCT01046513

Locations: 🇺🇸
National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore, Maryland, United States

Antagonist-Elicited Cannabis Withdrawal

Phase 1

Completed

Conditions: Cannabis
Dependence

First Posted Date: 2009-12-31

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Registration Number: NCT01041170

Locations: 🇺🇸
National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore, Maryland, United States
🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation

Phase 1

Completed

Conditions: Cannabis Abuse
Dependence
Pharmacokinetics
fMRI
Cannabis

First Posted Date: 2009-12-23

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 108

Registration Number: NCT01037608

Locations: 🇺🇸
National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore, Maryland, United States

Quantitation of Human Cerebral Nicotinie Receptors With 2[18F]FA-85380 and PET Healthy Non-smokers and Ex-Smokers and in Heavy and Light Situational Smokers

Completed

Conditions: Nicotine Addiction

First Posted Date: 2009-12-23

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 72

Registration Number: NCT01038245

Locations: 🇺🇸
National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy